NMOSD Part 3 - Overview of treatment, including goals, trigg

Name: NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies
Uploaded: 2024-02-29T00:00:00+00:00
Duration: 20 min 14 s
Description: In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOS

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

MS Minute: Emerging Myelin Repair Therapies in Multiple Sclerosis
MS Minute: Emerging Myelin Repair Therapies in Multiple Sclerosis
MS & Immune Disorders
MS Minute: Emerging Myelin Repair Therapies in Multiple Sclerosis
Mahtab Moniri, MPhil; Meher Sabharwal, BA (Hons)
Mahtab Moniri, MPhil; Meher Sabharwal, BA (Hons)
Advancing MOGAD Care
Advancing MOGAD Care
MS & Immune Disorders
Advancing MOGAD Care
Michael Levy, MD, PhD; Peter V. Sguigna, MD
Michael Levy, MD, PhD; Peter V. Sguigna, MD
Chimeric Antigen Receptor T-Cell Therapy for Progressive Multiple Sclerosis: Rationale, Evidence, and Therapeutic Potential
Chimeric Antigen Receptor T-Cell Therapy for Progressive Multiple Sclerosis: Rationale, Evidence, and Therapeutic Potential
MS & Immune Disorders
Chimeric Antigen Receptor T-Cell Therapy for Progressive Multiple Sclerosis: Rationale, Evidence, and Therapeutic Potential
Sarah Conway, MD; Kristin Galetta, MD, MSeD
Sarah Conway, MD; Kristin Galetta, MD, MSeD
Clinical Neuroinflammatory Mimics of Multiple Sclerosis
Clinical Neuroinflammatory Mimics of Multiple Sclerosis
MS & Immune Disorders
Clinical Neuroinflammatory Mimics of Multiple Sclerosis
Derrick Robertson, MD; Abigail Demers, BS
Derrick Robertson, MD; Abigail Demers, BS